NEU neuren pharmaceuticals limited

Ann: Compelling results for 2591 dose ranging study in PMS model, page-20

  1. 2,981 Posts.
    lightbulb Created with Sketch. 643
    There's two things working against us currently:

    - the manipulator / accumulator who is relentless (I'm now suspecting there is more than one)

    - timing

    Our timelines are pretty much set in concrete, which gives these predators ample room to move without (seemingly) any time constraints.

    I'm fairly convinced that the Lavender results will be sufficiently hidden from all interested parties which (for me) rules out Acadia making a compelling offer for all or part of our company.

    Which leaves feedback from Lilac as the only possible left-field disruptor.

    Even if that happens, our friends have essentially achieved what they set out to do, all that is happening now is icing on the cake for them.

    Travelling down the path with NEU for the past 10 years has been fun / interesting despite these manipulators, yet they are set to become one of the biggest beneficiaries.

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$12.54
Change
0.280(2.28%)
Mkt cap ! $1.559B
Open High Low Value Volume
$12.52 $12.73 $12.26 $8.152M 652.1K

Buyers (Bids)

No. Vol. Price($)
1 665 $12.50
 

Sellers (Offers)

Price($) Vol. No.
$12.55 235 1
View Market Depth
Last trade - 16.10pm 24/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.